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Original Article
Abstract Objective To screen for mutations in myosin-7A gene（MYO7A） in patients with prelingual
nonsyndromic hearing impairment. Methods 31 sporadic patients with congenital hearing impairment and 65
patients from 34 families with prelingual hereditary hearing impairment in China were tested in this study, and 100
hearing normal individuals were used as control. Genomic DNA isolated from whole blood of all subjects was
subjected to polymerase chain reaction(PCR) to amplify selected exons of MYO7A gene. The PCR products were
subsequently screened using single strand conformational polymorphism analysis(SSCP) and direct sequencing
when the fragments showed an abnormal electrophoretic pattern. Results GgA transition at position 617 in exon 7,
which would produce an A206G amino acid substitution, was detected in two patients but in none of the unaffected
members in the families. This heterozygous missense mutation happened within a highly conserved heptapeptide
sequence of MYO7A protein, and is closely relevant to preligual nonsyndromic deafness. Conclusions The
A206G substitution is possibly a new mutation to cause preligual nonsyndromic hearing impairment. Our results
provide evidence that exon 7 of MYO7A is a mutational hotspot in genetic hearing impairment.
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Introduction
Hereditary deafness is the most common
hereditary disease in Otolaryngology. It is estimated
that about 60% of the prelingual non-syndromic
hearing loss cases are caused by genetic factors. To
date, 18 genes have been reported to cause autosomal
recessive deafness (DFNB), 15 genes are involved in
autosomal dominant deafness (DFNA) and 1 gene
causes X-linked deafness (DFN).
Myosins belong to the superfamily of molecular
motor proteins (18 classes identified so far) and are
present in probably all eukaryotic cells. The proteins
bind to actin and use the energy from ATP hydrolysis
to generate force to pull itself along actin filaments.
They are involved in muscular contraction,
cytokinesis, short-range membrane/vesicle transport
and a host of other cellular processes.
So far, 6 classes of myosins, including MYO7A,
MYO15A, MYO6, MYO3A, MYO1A, MYH9
（nonmuscle myosin heavy chain 9） and MYH14
（nonmuscle myosin heavy chain 14）［1, 2, 3］, have proved
to be associated with genetic deafness disorders in
mammals. For example, mutations in MYO7A gene
are responsible for DFNB2, DFNA11 and Ush 1B
syndrome.
To ascertain the frequency and characteristics of
gene mutations in Chinese patients with prelingual
nonsyndromic hearing impairment, we screened for
mutations of MYO7A in 31 sporadic patients with
congenital hearing impairment and 65 patients from 34
families with prelingual hereditary hearing impairment
in China.
Materials and methods
31 sporadic patients and 65 patients from 34
families in China were investigated in this study. The
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affected patients in this study had congenital
sensorineural hearing impairment without any other
associated symptoms. All the individuals included in
this study gave a complete history and underwent
otoscopic examination and pure tone audiometry or
auditory brainstem response (ABR) test, as well as
general physical examination. In addition, vestibular
function was evaluated via bithermal caloric testing.
Peripheral blood samples were drawn from all the
patients and some family members, as well as 100
control individuals, after obtaining formal consent.
Genomic DNA(gDNA) samples were isolated from the
blood in these subjects.
SSCP Analysis
The human MYO7A gene spans 120 kb and
comprises 49 exons（Genebank accession number:
U39226）. Since 4 mutations have been reported to
cause nonsyndromic hearing loss[4, 5], the primers were
designed to amplified the coding region and flanking
intronic sequences of 4 exons (exon 4, 7, 15 and 28) of
the MYO7A gene. PCR was performed in 20 μl
volume containing 1μl diluted gDNA and 1μM of
oligonucleotide primers targeted to the 4 exons under
different calibrated conditions.
The products were subjected to single strand
conformational polymorphism analysis(SSCP) by
electrophoresis on 6% polyacryamide gel (contain 5%
glycerol) at 8W for 24 hours and result images were
scanned and analyzed using a Genescan scanner (Bio
Rad, USA).
DNA Sequencing
To define mutation/sequence changes, DNA
fragments that exhibited abnormal mobility shifts in
SSCP analysis, as well as normal fragments, were
reamplified, purified with Qiagen gel extraction kit and
then sequenced through an ABI377 sequencer. All
result PCR products were sequenced completely on
both strands, and analyzed with DNAStar software in
comparison to the sequence in Genebank.
Results
SSCP analysis showed abnormal mobility shifts in
PCR products for exon 7 of MYO7A in two patients
but not in the unaffected members in their families
(Figure 1). One of the cases was a boy who showed a
preligual bilateral profound sensorineural hearing loss
without any other associated symptoms, and his
mother also suffered from the same symptom. His
grandfather was said to be postlingually deaf also but
no gDNA sample was available from him because he
had deceased (Figure 2). Mutation screening for Cx26
exon
4
7
15
28
Forward primer（5’-3’）
CCTGAAGTGCGCAGCCTGG
ACCAGAGTTCCGAGGGTG
TCCTGGGACACTGGATGG
ACTGGCTGCTAGGAGGA
Reverse primer（5’-3’）
CCTGGACGGGCACCGG
AGGGGCCTGGGTCTATT
CATCCTTCACTCCCACCCTA
ATTGCTCTCCCCACAGTG
Products (bp)
242
261
289
278
Tm（℃）
60
58
60
56
Table .1 Primers designed for the four exons in MYO7A
Figure 1. DNA fragments exhibiting mobility shifts in SS-
CP analysis for the exon 7 of MYO7A in two patients
Figure 2. Pedigree of the affected family from Hunan
province, China.
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and Cx31 genes were applied to the family and
revealed no mutation in the two genes. The mutation
was not detected in the 100 unaffected individuals
involved in the study.
From sequencing the DNA fragments, a
heterozygous nucleotide transition GgA at position 617
in exon 7 was detected (Fig3). This mutation causes
Arg206Gln substitution within a highly conserved
heptapeptide sequence of protein MYO7A, and is
closely relevant to the preligual nonsyndromic hearing
impairment.
Discussion
Myosin-7A(MYO7A) belongs to the
unconventional myosin family. Unconventional
myosins are motor molecules with structurally
conserved heads that move along actin filaments using
their actin-activated ATPase activity. Mutations in
some myosins result in abnormalities in stereocilia in
the sensory cells in the inner ear. For example, when
MYO7A is missing, stereocilia become disorganized,
and they grow short with the loss of myosin XV.
Scanning electron microscopy shows that stereocilia
are malformed when the MYO7A, MYO15A, or
MYO6 genes are defective, suggesting that myosins
are essential for maintaining the structure of stereocilia
[1］. It has been shown that mutations in the MYO7A
gene are responsible for DFNB2, DFNA11 and Ush 1B
syndrome［5－8].
Exon 7 encodes the ATP-binding site of the motor
head of the protein. Several lines of evidence have led
us to suggest that the resultant amido-acid change may
impair the ATP-binding property of the protein. The
mutation results in the A206G substitution in exon 7,
which encodes the highly conserved heptapeptide
sequence that is invariant in all myosins of all classes.
This mutation resides in C-terminal to the ATP-binding
loop, at the base of the ATP binding pocket. In light of
the absolute evolutionary conservation of residues
within this region, it is expected that the A206G
mutation would severely impair the ATP-binding
function of the protein. In our study this mutation was
found to be segregated in the patients and there was no
mutation found in unaffected members in the family.
Human myosin VIIA
Mouse myosin VIIa
Rat myosin I heavy chain
human myosin I beta
chicken myosin I
rat myosin I
Human myosin IB heavy chain
human myosin ID
human myosin VA
mouse myosin VI
LEATPILEAFGNAKTIRNDNSSRFGKYIDIHFNKRGAIEGAKIEQYLLEK
LEATPILEAFGNAKTIRNDNSSRFGKYIDIHFNKRGAIEGAKIEQYLLSK
LQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQFDFKGAPVGGHILSYLLEK
LQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQFDFKGAPVGGHILSYLLEK
LQSNPVLEAFGNAKTIRNDNSSRFGKYMDVEFDFKGDPLGGVISNYLLEK
LKSNCVLEAFGNAKTNRNDNSSRFGKYMDINFDFKGDPIGGHINNYLLEK
L------EAFGNAKTIRNNNSSRFGKYMEIQFDLKGDPVGGRISNYLLEK
LQSNPLLEAFGNAKTVRNNNSSRFGKYFEIQFSRGGEPDGGKISNFLLEK
LTSNPIMESIGNAKTTRNDNSSRFGKYIEIGFDKRYRIIGANMRTYLLEK
VEANPLLEAFGNAKTVRNNNSSRFGKFVEIHFNEKSSVVGGFVSHYLLEK
Table. 2 Clustral W amino acid alignments of different myosins around the location of the mutation.
The 206 arginine (indicated by arrows) is highly conserved in most of myosin classes. Genebank accession numbers: human
myosin VIIA: u34277, mouse myosin VIIa: u81453, rat myosin I heavy chain: x74800, human myosin I beta: x98507, chicken my-
osin I: x58479, rat myosin I: x71997, myosin IB heavy chain: J02974, human myosin ID: u57053, human myosin VA: a53016,
mouse myosin VI: u49739.
Figure 3. Sequencing of DNA fragments. A heterozygous
nucleotide transition GgA at position 617 in exon 7 is
detected, which causes A206G substitution within a highly
conserved heptapeptide sequence of MYO7A protein.
A
B
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We conclude that this mutation is a possible cause for
the prelingual nonsyndromic deafness.
The MYO7A mutation observed here was hetero-
zygotic, and the pattern of the hearing loss in this fami-
ly was autosomal dominant with nonpenetrance. Even
though exons of the MYO7A gene other than exon 7
were not studied in this family, we speculate that muta-
tion on other allele in unscreened regions of the gene is
still possible. Weston(1996) screened a panel of 189 ge-
netically independent cases of Usher syndrome type I
for the presence of mutations in the motor domain of
MYO7A by analyzing 14 exons. They found 23 muta-
tions segregated with the disease, and 2 mutations
(R212H and R212C) accounting for the greatest per-
centage of observed mutant alleles (31% alleles). They
found some USH1B mutations present in heterozygous
state and presumed that the mutation on the other allele
was present in the unscreened regions of the gene［9］.
Although the MYO7A gene consists of 49 exons,
most of the deafness-causing mutations reported
previously are located in the first 14 exons, which
encode N-terminal coding portion of the motor domain
of MYO7A[7,9]. Previous report have shown that exon 7
of MYO7A is a mutational hotspot in genetic hearing
loss because some mutations in exon 7 have been
detected to be segregating with the hereditary
hearing impairment［10, 11］.
Due to its limitations, it is not possible to detect
all mutations in MYO7A using the SSCP technique.
Some mutations may exist in unscreened regions of the
gene. With regard to previous reports, we conclude that
exon 7 of MYO7A is a hotspot of deaf-causing
mutation. We expect that further investigations will
reveal other mutations in the myosins and their
phenotype of prelingual hearing impairment.
Summary
The current study identified an A206G mutation
in a prelingual nonsyndromic hearing loss family.
Sequence analysis suggests that the mutation was
responsible for the symptom in the family. With regard
to previous reports, we conclude that exon7 of
MYO7A is a hotspot of deafness-causing mutation.
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